Ceruloplasmin in neurodegenerative diseases
- PMID: 16269323
- DOI: 10.1016/j.brainresrev.2005.03.003
Ceruloplasmin in neurodegenerative diseases
Abstract
For decades, abnormalities in ceruloplasmin (Cp) synthesis have been associated with neurodegenerative disease. From the early observation that low circulating serum ceruloplasmin levels served as a marker for Wilson's disease to the recent characterization of a neurodegenerative disorder associated with a complete lack of serum ceruloplasmin, the link between Cp and neuropathology has strengthened. The mechanisms associated with these different central nervous system abnormalities are very distinct. In Wilson's disease, a defect in the P-type ATPase results in abnormal hepatic copper accumulation that eventually leaks into the circulation and is abnormally deposited in the brain. In this case, copper deposition results in the neurodegenerative phenotype observed. Patients with autosomal recessive condition, aceruloplasminemia, lack the ferroxidase activity inherent to the multi-copper oxidase ceruloplasmin and develop abnormal iron accumulation within the central nervous system. In the following review ceruloplasmin gene expression, structure and function will be presented and the role of ceruloplasmin in iron metabolism will be discussed. The molecular events underlying the different forms of neurodegeneration observed will be presented. Understanding the role of ceruloplasmin within the central nervous system is fundamental to further our understanding of the pathology observed. Is the ferroxidase function more essential than the antioxidant role? Does Cp help maintain nitrosothiol stores or does it oxidize critical brain substrates? The answers to these questions hold the promise for the treatment of devastating neurodegenerative conditions such as Alzheimer's and Parkinson's diseases. It is essential to further elucidate the mechanism of the neuronal injury associated with these disorders.
Similar articles
-
Ceruloplasmin in neurodegenerative diseases.Biochem Soc Trans. 2008 Dec;36(Pt 6):1277-81. doi: 10.1042/BST0361277. Biochem Soc Trans. 2008. PMID: 19021540 Review.
-
[The onset of psychiatric disorders and Wilson's disease].Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5. Encephale. 2007. PMID: 18789784 French.
-
Ceruloplasmin metabolism and function.Annu Rev Nutr. 2002;22:439-58. doi: 10.1146/annurev.nutr.22.012502.114457. Epub 2002 Apr 4. Annu Rev Nutr. 2002. PMID: 12055353 Review.
-
Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.Am J Clin Nutr. 1998 May;67(5 Suppl):972S-977S. doi: 10.1093/ajcn/67.5.972S. Am J Clin Nutr. 1998. PMID: 9587138 Review.
-
[Aceruloplasminemia].Rinsho Shinkeigaku. 2000 Dec;40(12):1290-2. Rinsho Shinkeigaku. 2000. PMID: 11464482 Review. Japanese.
Cited by
-
Cuproptosis regulator-mediated patterns associated with immune infiltration features and construction of cuproptosis-related signatures to guide immunotherapy.Front Immunol. 2022 Sep 29;13:945516. doi: 10.3389/fimmu.2022.945516. eCollection 2022. Front Immunol. 2022. PMID: 36248857 Free PMC article.
-
Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses.Psychiatry Investig. 2015 Apr;12(2):249-59. doi: 10.4306/pi.2015.12.2.249. Epub 2015 Mar 18. Psychiatry Investig. 2015. PMID: 25866527 Free PMC article.
-
New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia.Commun Biol. 2024 Jan 30;7(1):140. doi: 10.1038/s42003-024-05820-7. Commun Biol. 2024. PMID: 38291108 Free PMC article.
-
Ceruloplasmin and what it might do.J Neural Transm (Vienna). 2007;114(6):777-81. doi: 10.1007/s00702-007-0687-7. Epub 2007 Apr 4. J Neural Transm (Vienna). 2007. PMID: 17406962 Review.
-
High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study.Behav Brain Funct. 2008 Nov 18;4:52. doi: 10.1186/1744-9081-4-52. Behav Brain Funct. 2008. PMID: 19017404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous